Cargando…
Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery
Due to toxicity and compliance issues and the emergence of resistance to current medications new drugs for the treatment of Human African Trypanosomiasis are needed. A potential approach to developing novel anti-trypanosomal drugs is by inhibition of the 6-oxopurine salvage pathways which synthesise...
Autores principales: | Doleželová, Eva, Terán, David, Gahura, Ondřej, Kotrbová, Zuzana, Procházková, Michaela, Keough, Dianne, Špaček, Petr, Hocková, Dana, Guddat, Luke, Zíková, Alena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843355/ https://www.ncbi.nlm.nih.gov/pubmed/29481567 http://dx.doi.org/10.1371/journal.pntd.0006301 |
Ejemplares similares
-
Acyclic nucleoside phosphonates with adenine nucleobase inhibit Trypanosoma brucei adenine phosphoribosyltransferase in vitro
por: Doleželová, Eva, et al.
Publicado: (2021) -
Crystal structures and inhibition of Trypanosoma brucei hypoxanthine–guanine phosphoribosyltransferase
por: Terán, David, et al.
Publicado: (2016) -
Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of the 6-oxopurine phosphoribosyltransferases and have antimalarial activity
por: Keough, Dianne, et al.
Publicado: (2014) -
Trypanosoma brucei TbIF1 inhibits the essential F(1)-ATPase in the infectious form of the parasite
por: Panicucci, Brian, et al.
Publicado: (2017) -
Cultured bloodstream Trypanosoma brucei adapt to life without mitochondrial translation release factor 1
por: Procházková, Michaela, et al.
Publicado: (2018)